AI assistant
Sending…
DEXCOM INC — Director's Dealing 2021
Apr 16, 2021
30198_dirs_2021-04-16_f7fa0a1c-4075-45ef-a070-0ff65e9aacea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-04-15
Reporting Person: Flynn Paul R (EVP, Global Revenue)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-15 | Common Stock | S | 758 | $400.0 | Disposed | 12306 | Direct |
Footnotes
F1: On December 11, 2020, Mr. Flynn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Flynn. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 12,306 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,756 of which were granted on March 8, 2019 and shall vest through March 8, 2022.
More from DEXCOM INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Regulatory Filings
2026
May 28
Transaction in Own Shares
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Board/Management Information
2026
Mar 2
Director's Dealing
2026
Feb 26
Board/Management Information
2026
Feb 26
Director's Dealing
2026
Feb 17